Katja Harjula

Tampere, Finland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Protective Human Papillomavirus Type 16/18 Vaccine-Induced Neutralizing Antibody Levels Remain Elusive.

Protective Human Papillomavirus Type 16/18 Vaccine-Induced Neutralizing Antibody Levels Remain Elusive.

Journal: Open forum infectious diseases

Published: December 05, 2025

Head-to-head comparison of two human papillomavirus vaccines for efficacy against cervical intraepithelial neoplasia grade 3 and adenocarcinoma in situ-population-based follow-up of two cluster-randomized trials.

Head-to-head comparison of two human papillomavirus vaccines for efficacy against cervical intraepithelial neoplasia grade 3 and adenocarcinoma in situ-population-based follow-up of two cluster-randomized trials.

Journal: Frontiers in cellular and infection microbiology

Published: May 24, 2024

The quality of life of frequently vs. infrequently screened HPV vaccinated women.

The quality of life of frequently vs. infrequently screened HPV vaccinated women.

Journal: Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation

Published: November 27, 2023

Association of Chlamydia trachomatis infection with cervical atypia in adolescent women with short-term or long-term use of oral contraceptives: a longitudinal study in HPV vaccinated women.

Association of Chlamydia trachomatis infection with cervical atypia in adolescent women with short-term or long-term use of oral contraceptives: a longitudinal study in HPV vaccinated women.

Journal: BMJ open

Published: June 01, 2022

Human papillomavirus vaccine efficacy against invasive, HPV-positive cancers: population-based follow-up of a cluster-randomised trial.

Human papillomavirus vaccine efficacy against invasive, HPV-positive cancers: population-based follow-up of a cluster-randomised trial.

Journal: BMJ open

Published: February 12, 2022

Effectiveness of various human papillomavirus vaccination strategies: A community randomized trial in Finland.

Effectiveness of various human papillomavirus vaccination strategies: A community randomized trial in Finland.

Journal: Cancer medicine

Published: May 20, 2021

Effectiveness of the AS04-adjuvanted HPV-16/18 vaccine in reducing oropharyngeal HPV infections in young females-Results from a community-randomized trial.

Effectiveness of the AS04-adjuvanted HPV-16/18 vaccine in reducing oropharyngeal HPV infections in young females-Results from a community-randomized trial.

Journal: International journal of cancer

Published: July 18, 2019

Baseline findings and safety of infrequent vs. frequent screening of human papillomavirus vaccinated women.

Baseline findings and safety of infrequent vs. frequent screening of human papillomavirus vaccinated women.

Journal: International journal of cancer

Published: July 02, 2019

Gender-neutral vaccination provides improved control of human papillomavirus types 18/31/33/35 through herd immunity: Results of a community randomized trial (III).

Gender-neutral vaccination provides improved control of human papillomavirus types 18/31/33/35 through herd immunity: Results of a community randomized trial (III).

Journal: International journal of cancer

Published: January 26, 2018

Vaccination protects against invasive HPV-associated cancers.

Vaccination protects against invasive HPV-associated cancers.

Journal: International journal of cancer

Published: October 20, 2017

Ten-year follow-up of human papillomavirus vaccine efficacy against the most stringent cervical neoplasia end-point-registry-based follow-up of three cohorts from randomized trials.

Ten-year follow-up of human papillomavirus vaccine efficacy against the most stringent cervical neoplasia end-point-registry-based follow-up of three cohorts from randomized trials.

Journal: BMJ open

Published: August 20, 2017

Impact of gender-neutral or girls-only vaccination against human papillomavirus-Results of a community-randomized clinical trial (I).

Impact of gender-neutral or girls-only vaccination against human papillomavirus-Results of a community-randomized clinical trial (I).

Journal: International journal of cancer

Published: May 05, 2017

Showing 1-12 of 13

Last Updated: 09/26/2026